Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
17.68
+0.17 (0.97%)
At close: Feb 27, 2026, 4:00 PM EST
17.76
+0.08 (0.45%)
After-hours: Feb 27, 2026, 7:57 PM EST
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Healthpeak Properties stock have an average target of 19.5, with a low estimate of 17 and a high estimate of 25. The average target predicts an increase of 10.29% from the current stock price of 17.68.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 7 | 6 | 5 | 4 | 4 | 4 |
| Hold | 4 | 5 | 5 | 6 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 5, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +7.47% | Feb 4, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $19 → $18 | Hold | Maintains | $19 → $18 | +1.81% | Feb 2, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $17 | Hold | Initiates | $17 | -3.85% | Jan 9, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $21 → $17 | Strong Buy → Hold | Downgrades | $21 → $17 | -3.85% | Dec 16, 2025 |
Financial Forecast
Revenue This Year
2.83B
from 2.82B
Increased by 0.27%
Revenue Next Year
2.94B
from 2.83B
Increased by 4.03%
EPS This Year
0.26
from 0.10
Increased by 164.04%
EPS Next Year
0.29
from 0.26
Increased by 10.16%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 3.0B | 3.2B | |||
| Avg | 2.8B | 2.9B | |||
| Low | 2.7B | 2.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 6.1% | 11.3% | |||
| Avg | 0.3% | 4.0% | |||
| Low | -4.8% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.35 | 0.42 | |||
| Avg | 0.26 | 0.29 | |||
| Low | 0.16 | 0.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 246.5% | 59.1% | |||
| Avg | 164.0% | 10.2% | |||
| Low | 56.8% | -29.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.